Log in to save to my catalogue

Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer

Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12016232

Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer

About this item

Full title

Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer

Publisher

England: BioMed Central

Journal title

BMC cancer, 2025-04, Vol.25 (1), p.762

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies and most often diagnosed at an advanced stage. Identification of markers for the early diagnosis of PDAC is crucial. In this study, we aimed to identify novel mRNA biomarkers for diagnosing PDAC, focusing on early-stage tumorigenesis and associated immunological changes....

Alternative Titles

Full title

Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12016232

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12016232

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-025-14124-w

How to access this item